Aspen Pharmacare Holdings 관리
관리 기준 확인 4/4
Aspen Pharmacare Holdings CEO는 Stephen Saad, Jan2000 에 임명되었습니다 의 임기는 24.83 년입니다. 총 연간 보상은 ZAR 27.30M, 35.2% 로 구성됩니다. 35.2% 급여 및 64.8% 보너스(회사 주식 및 옵션 포함). 는 ZAR 9.45B 가치에 해당하는 회사 주식의 11.82% 직접 소유합니다. 9.45B. 경영진과 이사회의 평균 재임 기간은 각각 7.7 년과 5.6 년입니다.
주요 정보
Stephen Saad
최고 경영자
R27.3m
총 보상
| CEO 급여 비율 | 35.2% |
| CEO 임기 | 24.8yrs |
| CEO 소유권 | 11.8% |
| 경영진 평균 재임 기간 | 7.7yrs |
| 이사회 평균 재임 기간 | 5.6yrs |
최근 관리 업데이트
Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01
Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02Recent updates
Aspen Pharmacare Holdings' (JSE:APN) Conservative Accounting Might Explain Soft Earnings
Oct 10Here's Why Aspen Pharmacare Holdings (JSE:APN) Has A Meaningful Debt Burden
Oct 01Aspen Pharmacare Holdings (JSE:APN) Has Announced That It Will Be Increasing Its Dividend To ZAR3.59
Sep 10We Think Aspen Pharmacare Holdings (JSE:APN) Can Stay On Top Of Its Debt
May 08Aspen Pharmacare Holdings Limited's (JSE:APN) P/E Still Appears To Be Reasonable
Mar 05Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Dec 22Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation Is Looking A Bit Stretched At The Moment
Dec 01Aspen Pharmacare Holdings (JSE:APN) Has A Pretty Healthy Balance Sheet
Mar 31With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Makes An Interesting Case
Jan 11These 4 Measures Indicate That Aspen Pharmacare Holdings (JSE:APN) Is Using Debt Reasonably Well
Oct 22We Ran A Stock Scan For Earnings Growth And Aspen Pharmacare Holdings (JSE:APN) Passed With Ease
Oct 06Aspen Pharmacare Holdings' (JSE:APN) Upcoming Dividend Will Be Larger Than Last Year's
Sep 21Aspen Pharmacare Holdings Limited (JSE:APN) Analysts Just Cut Their EPS Forecasts Substantially
Sep 08Aspen Pharmacare Holdings (JSE:APN) Is Increasing Its Dividend To ZAR3.26
Sep 07Here's Why We Think Aspen Pharmacare Holdings (JSE:APN) Might Deserve Your Attention Today
Jun 15Aspen Pharmacare Holdings (JSE:APN) Seems To Use Debt Quite Sensibly
Apr 02With EPS Growth And More, Aspen Pharmacare Holdings (JSE:APN) Is Interesting
Mar 16An Intrinsic Calculation For Aspen Pharmacare Holdings Limited (JSE:APN) Suggests It's 33% Undervalued
Mar 02Is Aspen Pharmacare Holdings (JSE:APN) A Risky Investment?
Dec 23Shareholders Will Probably Not Have Any Issues With Aspen Pharmacare Holdings Limited's (JSE:APN) CEO Compensation
Dec 02We Think Aspen Pharmacare Holdings' (JSE:APN) Robust Earnings Are Conservative
Oct 11After Leaping 42% Aspen Pharmacare Holdings Limited (JSE:APN) Shares Are Not Flying Under The Radar
Sep 30Aspen Pharmacare Holdings Limited (JSE:APN) Looks Just Right With A 42% Price Jump
Sep 30CEO 보상 분석
| 날짜 | 총 보상 | 급여 | 회사 수익 |
|---|---|---|---|
| Jun 30 2024 | R27m | R10m | R4b |
| Mar 31 2024 | n/a | n/a | R5b |
| Dec 31 2023 | n/a | n/a | R5b |
| Sep 30 2023 | n/a | n/a | R5b |
| Jun 30 2023 | R24m | R9m | R5b |
| Mar 31 2023 | n/a | n/a | R6b |
| Dec 31 2022 | n/a | n/a | R6b |
| Sep 30 2022 | n/a | n/a | R6b |
| Jun 30 2022 | R23m | R9m | R6b |
| Mar 31 2022 | n/a | n/a | R6b |
| Dec 31 2021 | n/a | n/a | R6b |
| Sep 30 2021 | n/a | n/a | R5b |
| Jun 30 2021 | R24m | R8m | R5b |
| Mar 31 2021 | n/a | n/a | R4b |
| Dec 31 2020 | n/a | n/a | R4b |
| Sep 30 2020 | n/a | n/a | R4b |
| Jun 30 2020 | R23m | R8m | R3b |
| Mar 31 2020 | n/a | n/a | R3b |
| Dec 31 2019 | n/a | n/a | R870m |
| Sep 30 2019 | n/a | n/a | R1b |
| Jun 30 2019 | R14m | R8m | R2b |
| Mar 31 2019 | n/a | n/a | R3b |
| Dec 31 2018 | n/a | n/a | R5b |
| Sep 30 2018 | n/a | n/a | R5b |
| Jun 30 2018 | R17m | R7m | R6b |
보상 대 시장: Stephen 의 총 보상 ($USD 1.56M )은 ZA 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 1.55M ).
보상과 수익: Stephen 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.
CEO
Stephen Saad (60 yo)
24.8yrs
테뉴어
R27,303,000
보상
Mr. Stephen Bradley Saad, BCom, CA(SA), serves as the Group Chief Executive Officer of Aspen Pharmacare Canada Inc. Mr. Stephen has been the Group Chief Executive Officer of Aspen Pharmacare Holdings Limit...
리더십 팀
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Group CEO & Executive Director | 24.8yrs | R27.30m | 11.82% ZAR 9.4b | |
| Group CFO & Executive Director | 25.8yrs | R16.66m | 데이터 없음 | |
| Group Chief Operations Officer & Responsible Pharmacist | 11yrs | R17.18m | 데이터 없음 | |
| Group Chief Advisor | 2.8yrs | R11.14m | 4.32% ZAR 3.5b | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | 데이터 없음 | |
| Group Chief Strategic Development Officer | 4.5yrs | R12.81m | 데이터 없음 | |
| Investor Relations Manager | no data | 데이터 없음 | 데이터 없음 | |
| Group Company Secretary & Chief of Staff | less than a year | 데이터 없음 | 데이터 없음 | |
| Regional Chief Executive Officer of Asia Pacific | 10.8yrs | 데이터 없음 | 데이터 없음 | |
| Chief Executive Officer of Aspen Global Incorporated | 7.7yrs | 데이터 없음 | 데이터 없음 | |
| Corporate Affairs & Investor Relations Executive | no data | 데이터 없음 | 데이터 없음 |
7.7yrs
평균 재임 기간
54.5yo
평균 연령
경험이 풍부한 관리: APN 의 관리팀은 노련하고 경험 (평균 재직 기간 7.7 년)입니다.
이사회 구성원
| 이름 | 위치 | 테뉴어 | 보상 | 소유권 |
|---|---|---|---|---|
| Group CEO & Executive Director | 25.8yrs | R27.30m | 11.82% ZAR 9.4b | |
| Group CFO & Executive Director | 2.8yrs | R16.66m | 데이터 없음 | |
| Group Chief Corporate Services Officer & Executive Director | less than a year | R13.79m | 데이터 없음 | |
| Lead Independent Non-Executive Director | 5.6yrs | R1.27m | 데이터 없음 | |
| Non-Executive Director | 25.8yrs | R551.00k | 데이터 없음 | |
| Independent Non-Executive Chairman | 12.6yrs | R1.49m | 데이터 없음 | |
| Independent Non-Executive Director | 2.9yrs | R1.08m | 데이터 없음 | |
| Non-Executive Director | 9.8yrs | R427.00k | 데이터 없음 | |
| Independent Non-Executive Director | 6.3yrs | R1.14m | 데이터 없음 | |
| Independent Non-Executive Director | less than a year | R183.00k | 데이터 없음 | |
| Independent Non-Executive Director | 5.6yrs | R432.00k | 데이터 없음 |
5.6yrs
평균 재임 기간
57yo
평균 연령
경험이 풍부한 이사회: APN 의 이사회는 경험(평균 재직 기간 5.6 년)으로 간주됩니다.